Detalles de la búsqueda
1.
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults: Réseau canadien pour les traitements de l'humeur et de l'anxiété (CANMAT) 2023 : Mise à jour des lignes directrices cliniques pour la prise en charge du trouble dépressif majeur chez les adultes.
Can J Psychiatry;
: 7067437241245384, 2024 May 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38711351
2.
The Differential Relation of Emotional, Physical, and Sexual Abuse Histories to Antidepressant Treatment Remission and Persistence of Anhedonia in Major Depression: A CAN-BIND-1 Report.
Can J Psychiatry;
68(8): 586-595, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36785892
3.
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) recommendations for the management of patients with bipolar disorder with mixed presentations.
Bipolar Disord;
23(8): 767-788, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34599629
4.
Impacts on Quality of Life with Escitalopram Monotherapy and Aripiprazole Augmentation in Patients with Major Depressive Disorder: A CAN-BIND Report.
Pharmacopsychiatry;
54(5): 225-231, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-33652477
5.
Cognition and Its Association with Psychosocial and Occupational Functioning during Treatment with Escitalopram in Patients with Major Depressive Disorder: A CAN-BIND-1 Report: La Cognition Et Son Association Avec Le Fonctionnement Psychosocial Et Professionnel Durant Le Traitement Par Escitalopram Chez Des Patients Souffrant De Trouble Dépressif Majeur: Une Étude Can-Bind-1.
Can J Psychiatry;
66(9): 798-806, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33353384
6.
The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Recommendations for the Use of Racemic Ketamine in Adults with Major Depressive Disorder: Recommandations Du Groupe De Travail Du Réseau Canadien Pour Les Traitements De L'humeur Et De L'anxiété (Canmat) Concernant L'utilisation De La Kétamine Racémique Chez Les Adultes Souffrant De Trouble Dépressif Majeur.
Can J Psychiatry;
66(2): 113-125, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33174760
7.
Childhood maltreatment and cognitive functioning in patients with major depressive disorder: a CAN-BIND-1 report.
Psychol Med;
50(15): 2536-2547, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31583989
8.
The Effects of Probiotics on Symptoms of Depression: Protocol for a Double-Blind Randomized Placebo-Controlled Trial.
Neuropsychobiology;
79(1): 108-116, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-30759442
9.
Functional Recovery in Major Depressive Disorder: Providing Early Optimal Treatment for the Individual Patient.
Int J Neuropsychopharmacol;
21(2): 128-144, 2018 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29024974
10.
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder.
Bipolar Disord;
20(2): 97-170, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29536616
11.
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 6. Special Populations: Youth, Women, and the Elderly.
Can J Psychiatry;
61(9): 588-603, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27486149
12.
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 1. Disease Burden and Principles of Care.
Can J Psychiatry;
61(9): 510-23, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27486151
13.
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 5. Complementary and Alternative Medicine Treatments.
Can J Psychiatry;
61(9): 576-87, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27486153
14.
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 2. Psychological Treatments.
Can J Psychiatry;
61(9): 524-39, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27486150
15.
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 4. Neurostimulation Treatments.
Can J Psychiatry;
61(9): 561-75, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27486154
16.
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological Treatments.
Can J Psychiatry;
61(9): 540-60, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27486148
17.
Functional neuroimaging biomarkers of anhedonia response to escitalopram plus adjunct aripiprazole treatment for major depressive disorder.
BJPsych Open;
10(1): e18, 2024 Jan 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38179598
18.
Relation of hippocampal volume and SGK1 gene expression to treatment remission in major depression is moderated by childhood maltreatment: A CAN-BIND-1 report.
Eur Neuropsychopharmacol;
78: 71-80, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38128154
19.
Data and alternative models describing the associations among non-infection pandemic stress, event-related rumination, depression, and anxiety.
Data Brief;
46: 108864, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36589627
20.
The course of insomnia symptoms during the acute treatment of major depressive disorder: A CAN-BIND-1 report.
Psychiatry Res;
325: 115222, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37163883